Search
Now showing items 1-4 of 4
Open-label study of absorption and clearance of 1% voriconazole eye drops
(
American Society for Microbiology
, 2016 , Article)
Twenty participants undergoing elective cataract surgery received 1% voriconazole eye drops (1 drop per eye) either 20, 40, 60, or 80 min before surgery. Median voriconazole concentrations of 1.9 to 3.2 mg/liter in aqueous ...
Cost effectiveness of caspofungin vs. voriconazole for empiric therapy in Turkey
(
Blackwell Publishing Ltd
, 2014 , Article)
Invasive fungal infections from febrile neutropenia are associated with significant cost and mortality. The mainstay of treatment has been liposomal amphotericin B, however, echinocandins and azoles have shown promise as ...
Pharmacoeconomics of voriconazole
(
Nova Science Publishers, Inc.
, 2015 , Book chapter)
Voriconazole is a second-generation triazole that is a synthesized derivative of fluconazole. It first appeared in the US market in 2002. Voriconazole is available in oral and intravenous dosage forms, and does have excellent ...
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey
(
BMC
, 2013 , Article)
Background: Invasive fungal infections (IFI) are associated with considerable expense and mortality on healthcare systems. There is a need to provide evidence of both clinical efficacy and value for money with any health ...